The recognition of β cell dedifferentiation in type 2 diabetes raises the translational relevance of mechanisms that direct and maintain β cell identity. LIM domain–binding protein 1 (LDB1) nucleates multimeric transcriptional complexes and establishes promoter-enhancer looping, thereby directing fate assignment and maturation of progenitor populations. Many terminally differentiated endocrine cell types, however, remain enriched for LDB1, but its role is unknown. Here, we have demonstrated a requirement for LDB1 in maintaining the terminally differentiated status of pancreatic β cells. Inducible ablation of LDB1 in mature β cells impaired insulin secretion and glucose homeostasis. Transcriptomic analysis of LDB1-depleted β cells revealed the collapse of the terminally differentiated gene program, indicated by a loss of β cell identity genes and induction of the endocrine progenitor factor neurogenin 3 (NEUROG3). Lineage tracing confirmed that LDB1-depleted, insulin-negative β cells express NEUROG3 but do not adopt alternate endocrine cell fates. In primary mouse islets, LDB1 and its LIM homeodomain–binding partner islet 1 (ISL1) were coenriched at chromatin sites occupied by pancreatic and duodenal homeobox 1 (PDX1), NK6 homeobox 1 (NKX6.1), forkhead box A2 (FOXA2), and NK2 homeobox 2 (NKX2.2) — factors that co-occupy active enhancers in 3D chromatin domains in human islets. Indeed, LDB1 was enriched at active enhancers in human islets. Thus, LDB1 maintains the terminally differentiated state of β cells and is a component of active enhancers in both murine and human islets.
Benjamin N. Ediger, Hee-Woong Lim, Christine Juliana, David N. Groff, LaQueena T. Williams, Giselle Dominguez, Jin-Hua Liu, Brandon L. Taylor, Erik R. Walp, Vasumathi Kameswaran, Juxiang Yang, Chengyang Liu, Chad S. Hunter, Klaus H. Kaestner, Ali Naji, Changhong Li, Maike Sander, Roland Stein, Lori Sussel, Kyoung-Jae Won, Catherine Lee May, Doris A. Stoffers
Title and authors | Publication | Year |
---|---|---|
The Anna Karenina Model of β-Cell Maturation in Development and Their Dedifferentiation in Type 1 and Type 2 Diabetes
SD Nimkulrat, MN Bernstein, Z Ni, J Brown, C Kendziorski, B Blum |
Diabetes | 2021 |
Functional maturation of immature β cells: A roadblock for stem cell therapy for type 1 diabetes
ZY Sun, TY Yu, FX Jiang, W Wang |
World journal of stem cells | 2021 |
CBP/p300 HAT maintains the gene network critical for β cell identity and functional maturity
L Zhang, C Sheng, F Zhou, K Zhu, S Wang, Q Liu, M Yuan, Z Xu, Y Liu, J Lu, J Liu, L Zhou, X Wang |
Cell Death and Disease | 2021 |
Dysregulation of the Pdx1/Ovol2/Zeb2 axis in dedifferentiated β-cells triggers the induction of genes associated with epithelial–mesenchymal transition in diabetes
DS de Jesus, TC Mak, YF Wang, Y von Ohlen, Y Bai, E Kane, P Chabosseau, CM Chahrour, W Distaso, V Salem, A Tomas, M Stoffel, GA Rutter, M Latreille |
Molecular Metabolism | 2021 |
LDB1-mediated transcriptional complexes are sensitive to islet stress
Y Liu, JD Kepple, A Shalev, CS Hunter |
Islets | 2021 |
Cooperation of LIM domain‐binding 2 (LDB2) with EGR in the pathogenesis of schizophrenia
T Ohnishi, Y Kiyama, F ArimaYoshida, M Kadota, T Ichikawa, K Yamada, A Watanabe, H Ohba, K Tanaka, A Nakaya, Y Horiuchi, Y Iwayama, M Toyoshima, I Ogawa, C ShimamotoMitsuyama, M Maekawa, S Balan, M Arai, M Miyashita, K Toriumi, Y Nozaki, R Kurokawa, K Suzuki, A Yoshikawa, T Toyota, T Hosoya, H Okuno, H Bito, M Itokawa, S Kuraku, T Manabe, T Yoshikawa |
EMBO Molecular Medicine | 2021 |
GLIS3: A Critical Transcription Factor in Islet β-Cell Generation
DW Scoville, AM Jetten |
Cells | 2021 |